These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 30167098)
21. NMO spectrum disorders comprise the major portion of CNS inflammatory diseases in Thai patients: A cross sectional study. Apiwattanakul M; Kasemsuk C Mult Scler Relat Disord; 2014 Jan; 3(1):61-6. PubMed ID: 25877974 [TBL] [Abstract][Full Text] [Related]
22. A comparative evaluation of different neuromyelitis optica spectrum disorder sets of criteria. Papeix C; Beigneux Y; Maillart E; de Seze J; Lubetzki C; Vukusic S; Collongues N; Marignier R Eur J Neurol; 2020 Nov; 27(11):2250-2256. PubMed ID: 32559008 [TBL] [Abstract][Full Text] [Related]
23. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese. Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340 [TBL] [Abstract][Full Text] [Related]
24. Experimental animal models of aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: progress and shortcomings. Duan T; Verkman AS Brain Pathol; 2020 Jan; 30(1):13-25. PubMed ID: 31587392 [TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea. Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965 [TBL] [Abstract][Full Text] [Related]
26. Beneficial effects of intravenous immunoglobulin as an add-on therapy to azathioprine for NMO-IgG-seropositive neuromyelitis optica spectrum disorders. Lim YM; Kim H; Lee EJ; Kim HW; Kim HJ; Kim KK Mult Scler Relat Disord; 2020 Jul; 42():102109. PubMed ID: 32387973 [TBL] [Abstract][Full Text] [Related]
27. Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience. Unni N; Barhate K; Ahmad N; Ganeshan M; Singhal B Ann Indian Acad Neurol; 2013 Jul; 16(3):376-9. PubMed ID: 24101820 [TBL] [Abstract][Full Text] [Related]
28. Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica. Tasaki A; Shimizu F; Sano Y; Fujisawa M; Takahashi T; Haruki H; Abe M; Koga M; Kanda T J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):419-30. PubMed ID: 24259591 [TBL] [Abstract][Full Text] [Related]
29. Validation of claims-based diagnoses of adult and pediatric neuromyelitis optica spectrum disorder and variations in diagnostic evaluation and treatment initiation. Gmuca S; Hardy DI; Narula S; Stoll S; Harris J; Zhao Y; Xiao R; Weiss PF; Waldman AT; Gerber JS Mult Scler Relat Disord; 2020 Jan; 37():101488. PubMed ID: 31706167 [TBL] [Abstract][Full Text] [Related]
30. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease. Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216 [TBL] [Abstract][Full Text] [Related]
32. Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders. Asseyer S; Schmidt F; Chien C; Scheel M; Ruprecht K; Bellmann-Strobl J; Brandt AU; Paul F Mult Scler J Exp Transl Clin; 2018; 4(3):2055217318796684. PubMed ID: 30186620 [TBL] [Abstract][Full Text] [Related]
33. Resolution of inflammation in neuromyelitis optica spectrum disorders. Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851 [TBL] [Abstract][Full Text] [Related]
34. NMO-IgG Induce Interleukin-6 Release via Activation of the NF-κB Signaling Pathway in Astrocytes. Wang Y; Zhang J; Chang H; Wang H; Xu W; Cong H; Zhang X; Liu J; Yin L Neuroscience; 2022 Aug; 496():96-104. PubMed ID: 35659638 [TBL] [Abstract][Full Text] [Related]
35. Diagnosis and management of neuromyelitis optica spectrum disorders - An update. Bruscolini A; Sacchetti M; La Cava M; Gharbiya M; Ralli M; Lambiase A; De Virgilio A; Greco A Autoimmun Rev; 2018 Mar; 17(3):195-200. PubMed ID: 29339316 [TBL] [Abstract][Full Text] [Related]